Evidence map›Paper›PMID 32503319›Full record

ArticleMaterials (Basel, Switzerland)2020

Superiority of Cellulose Non-Solvent Chemical Modification over Solvent-Involving Treatment: Solution for Green Chemistry (Part I).

Stefan Cichosz, Anna Masek

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Advances in Natural Fibers and Polymers.Materials (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stefan CichoszFaculty of Chemistry, Institute of Polymer and Dye Technology, Lodz University of Technology, 90-924 Lodz, Stefanowskiego 12/16, Poland.ORCID 0000-0003-3076-7766
Anna MasekFaculty of Chemistry, Institute of Polymer and Dye Technology, Lodz University of Technology, 90-924 Lodz, Stefanowskiego 12/16, Poland.ORCID 0000-0003-3785-1995
Lodz University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the following article, a new approach of cellulose modification, which does not incorporate any solvents (NS), is introduced. It is compared for the first time with the traditional solvent-involving (S) treatment. The analysed non-solvent modification process is carried out in a planetary mill. This provides the opportunity for cellulose mechanical degradation, decreasing its size, simultaneously with ongoing silane coupling agent grafting. Fourier-transform infrared spectroscopy (FT-IR) indicated the possibility of intense cleavage of the glucose rings in the cellulose chains during the mechano-chemical treatment. This effect was proved with dynamic light scattering (DLS) results-the size of the particles decreased. Moreover, according to differential scanning calorimetry (DSC) investigation, modified samples exhibited decreased moisture content and a drop in the adsorbed water evaporation temperature. The performed research proved the superiority of the mechano-chemical treatment over regular chemical modification. The one-pot bio-filler modification approach, as a solution fulfilling green chemistry requirements, as well as compromising the sustainable development rules, was presented. Furthermore, this research may contribute significantly to the elimination of toxic solvents from cellulose modification processes.

Indexed as

cellulosegreen chemistrynon-solvent modificationsilane

Identifiers

PMID32503319
PMCPMC7321458
OpenAlexW3033033540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.